Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Action inhibitors |
Mechanism ZER1 inhibitors(zyg-11 related cell cycle regulator inhibitors), ZYG11B inhibitors(zyg-11 family member B, cell cycle regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arteriosclerosis | Discovery | - | 04 Jun 2024 | |
| Diabetes Mellitus | Discovery | - | 04 Jun 2024 | |
| Digestive System Disorders | Discovery | - | 04 Jun 2024 | |
| Immune System Diseases | Discovery | - | 04 Jun 2024 | |
| Infectious Diseases | Discovery | - | 04 Jun 2024 | |
| Lung Diseases, Interstitial | Discovery | - | 04 Jun 2024 | |
| Myeloproliferative Disorders | Discovery | - | 04 Jun 2024 | |
| Neoplasms | Discovery | - | 04 Jun 2024 | |
| Nervous System Diseases | Discovery | - | 04 Jun 2024 | |
| Other Diseases | Discovery | - | 04 Jun 2024 |





